- Home
- ZENA vs QNCX Comparison
ZENA vs QNCX Comparison
Compare ZENA & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZENA
- QNCX
- Stock Information
- Founded
- ZENA 2017
- QNCX 2012
- Country
- ZENA Canada
- QNCX United States
- Employees
- ZENA N/A
- QNCX N/A
- Industry
- ZENA
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZENA
- QNCX Health Care
- Exchange
- ZENA NYSE
- QNCX Nasdaq
- Market Cap
- ZENA 51.9M
- QNCX 44.0M
- IPO Year
- ZENA N/A
- QNCX 2019
- Fundamental
- Price
- ZENA $2.50
- QNCX $1.04
- Analyst Decision
- ZENA
- QNCX Strong Buy
- Analyst Count
- ZENA 0
- QNCX 5
- Target Price
- ZENA N/A
- QNCX $8.00
- AVG Volume (30 Days)
- ZENA 207.5K
- QNCX 128.6K
- Earning Date
- ZENA 01-01-0001
- QNCX 05-12-2025
- Dividend Yield
- ZENA N/A
- QNCX N/A
- EPS Growth
- ZENA N/A
- QNCX N/A
- EPS
- ZENA N/A
- QNCX N/A
- Revenue
- ZENA $1,364,714.00
- QNCX N/A
- Revenue This Year
- ZENA N/A
- QNCX N/A
- Revenue Next Year
- ZENA N/A
- QNCX N/A
- P/E Ratio
- ZENA N/A
- QNCX N/A
- Revenue Growth
- ZENA 7.43
- QNCX N/A
- 52 Week Low
- ZENA $1.41
- QNCX $0.51
- 52 Week High
- ZENA $12.43
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- ZENA N/A
- QNCX 35.61
- Support Level
- ZENA N/A
- QNCX $0.97
- Resistance Level
- ZENA N/A
- QNCX $1.10
- Average True Range (ATR)
- ZENA 0.00
- QNCX 0.09
- MACD
- ZENA 0.00
- QNCX 0.01
- Stochastic Oscillator
- ZENA 0.00
- QNCX 29.91
About ZENA ZENATECH INC
ZenaTech Inc is a enterprise software technology company that specializes in mission-critical cloud-based applications integrated with smart hardware to deliver innovative solutions across diverse industries. The Company operates in software development technology, sales, and distribution. The Company is also developing a drone manufacturing, sales, and distribution business. The company operates in two segments which is software development technology, sales, and distribution, as well as drone manufacturing, sales, and distribution.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.